1. Home
  2. IKNA vs UONE Comparison

IKNA vs UONE Comparison

Compare IKNA & UONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • UONE
  • Stock Information
  • Founded
  • IKNA 2016
  • UONE 1980
  • Country
  • IKNA United States
  • UONE United States
  • Employees
  • IKNA N/A
  • UONE N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • UONE Broadcasting
  • Sector
  • IKNA Health Care
  • UONE Consumer Discretionary
  • Exchange
  • IKNA Nasdaq
  • UONE Nasdaq
  • Market Cap
  • IKNA 80.8M
  • UONE 65.7M
  • IPO Year
  • IKNA 2021
  • UONE N/A
  • Fundamental
  • Price
  • IKNA $1.71
  • UONE $1.48
  • Analyst Decision
  • IKNA Buy
  • UONE
  • Analyst Count
  • IKNA 2
  • UONE 0
  • Target Price
  • IKNA $3.00
  • UONE N/A
  • AVG Volume (30 Days)
  • IKNA 60.6K
  • UONE 95.6K
  • Earning Date
  • IKNA 11-07-2024
  • UONE 11-12-2024
  • Dividend Yield
  • IKNA N/A
  • UONE N/A
  • EPS Growth
  • IKNA N/A
  • UONE N/A
  • EPS
  • IKNA N/A
  • UONE N/A
  • Revenue
  • IKNA $659,000.00
  • UONE $452,891,000.00
  • Revenue This Year
  • IKNA N/A
  • UONE N/A
  • Revenue Next Year
  • IKNA N/A
  • UONE N/A
  • P/E Ratio
  • IKNA N/A
  • UONE N/A
  • Revenue Growth
  • IKNA N/A
  • UONE N/A
  • 52 Week Low
  • IKNA $1.22
  • UONE $1.23
  • 52 Week High
  • IKNA $2.32
  • UONE $4.50
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 49.85
  • UONE 49.50
  • Support Level
  • IKNA $1.71
  • UONE $1.34
  • Resistance Level
  • IKNA $1.77
  • UONE $1.72
  • Average True Range (ATR)
  • IKNA 0.05
  • UONE 0.15
  • MACD
  • IKNA -0.00
  • UONE 0.00
  • Stochastic Oscillator
  • IKNA 38.46
  • UONE 36.84

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About UONE Urban One Inc.

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: